The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss of ability to fight against the organism that causes disease.

The global HIV Therapeutics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of HIV Therapeutics in various end use industries. The expanding demands from the Hospitals, Clinics and Labs,, are propelling HIV Therapeutics market. Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) segment is estimated at % CAGR for the next seven-year period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for HIV Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global HIV Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global HIV Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, HIV Therapeutics sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of HIV Therapeutics covered in this report include Boehringer Ingelheim International GmbH, Merck & Co., ViiV Healthcare, AbbVie, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb, Gilead Sciences and Johnson & Johnson, etc.

The global HIV Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Boehringer Ingelheim International GmbH

Merck & Co.

ViiV Healthcare

AbbVie

F. Hoffmann-La Roche Ltd.

Teva Pharmaceutical Industries Ltd.

Bristol-Myers Squibb

Gilead Sciences

Johnson & Johnson

Cipla Limited

Scope of HIV Therapeutics - Market Report

Report Metric	Details
Report Name	HIV Therapeutics - Market
CAGR	5%
Global HIV Therapeutics market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global HIV Therapeutics market, Segment by Type:	Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Entry and Fusion Inhibitors Protease Inhibitors (PIs) Integrase Inhibitors Coreceptor Antagonists
Global HIV Therapeutics market, by Application	Hospitals Clinics Labs
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of HIV Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What are the Application segmentation covered in the HIV Therapeutics - Market report?

Ans: The Applications covered in the HIV Therapeutics - Market report are Hospitals, Clinics, Labs

What are the Type segmentation covered in the HIV Therapeutics - Market report?

Ans: The Types covered in the HIV Therapeutics - Market report are Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs), Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), Entry and Fusion Inhibitors, Protease Inhibitors (PIs), Integrase Inhibitors, Coreceptor Antagonists

1 Market Overview of HIV Therapeutics

1.1 HIV Therapeutics Market Overview

1.1.1 HIV Therapeutics Product Scope

1.1.2 HIV Therapeutics Market Status and Outlook

1.2 Global HIV Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029

1.3 Global HIV Therapeutics Market Size by Region (2018-2029)

1.4 Global HIV Therapeutics Historic Market Size by Region (2018-2023)

1.5 Global HIV Therapeutics Market Size Forecast by Region (2024-2029)

1.6 Key Regions, HIV Therapeutics Market Size (2018-2029)

1.6.1 North America HIV Therapeutics Market Size (2018-2029)

1.6.2 Europe HIV Therapeutics Market Size (2018-2029)

1.6.3 Asia-Pacific HIV Therapeutics Market Size (2018-2029)

1.6.4 Latin America HIV Therapeutics Market Size (2018-2029)

1.6.5 Middle East & Africa HIV Therapeutics Market Size (2018-2029)

2 HIV Therapeutics Market by Type

2.1 Introduction

2.1.1 Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)

2.1.2 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

2.1.3 Entry and Fusion Inhibitors

2.1.4 Protease Inhibitors (PIs)

2.1.5 Integrase Inhibitors

2.1.6 Coreceptor Antagonists

2.2 Global HIV Therapeutics Market Size by Type: 2018 VS 2022 VS 2029

2.2.1 Global HIV Therapeutics Historic Market Size by Type (2018-2023)

2.2.2 Global HIV Therapeutics Forecasted Market Size by Type (2024-2029)

2.3 Key Regions Market Size by Type

2.3.1 North America HIV Therapeutics Revenue Breakdown by Type (2018-2029)

2.3.2 Europe HIV Therapeutics Revenue Breakdown by Type (2018-2029)

2.3.3 Asia-Pacific HIV Therapeutics Revenue Breakdown by Type (2018-2029)

2.3.4 Latin America HIV Therapeutics Revenue Breakdown by Type (2018-2029)

2.3.5 Middle East and Africa HIV Therapeutics Revenue Breakdown by Type (2018-2029)

3 HIV Therapeutics Market Overview by Application

3.1 Introduction

3.1.1 Hospitals

3.1.2 Clinics

3.1.3 Labs

3.2 Global HIV Therapeutics Market Size by Application: 2018 VS 2022 VS 2029

3.2.1 Global HIV Therapeutics Historic Market Size by Application (2018-2023)

3.2.2 Global HIV Therapeutics Forecasted Market Size by Application (2024-2029)

3.3 Key Regions Market Size by Application

3.3.1 North America HIV Therapeutics Revenue Breakdown by Application (2018-2029)

3.3.2 Europe HIV Therapeutics Revenue Breakdown by Application (2018-2029)

3.3.3 Asia-Pacific HIV Therapeutics Revenue Breakdown by Application (2018-2029)

3.3.4 Latin America HIV Therapeutics Revenue Breakdown by Application (2018-2029)

3.3.5 Middle East and Africa HIV Therapeutics Revenue Breakdown by Application (2018-2029)

4 HIV Therapeutics Competition Analysis by Players

4.1 Global HIV Therapeutics Market Size by Players (2018-2023)

4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in HIV Therapeutics as of 2022)

4.3 Date of Key Players Enter into HIV Therapeutics Market

4.4 Global Top Players HIV Therapeutics Headquarters and Area Served

4.5 Key Players HIV Therapeutics Product Solution and Service

4.6 Competitive Status

4.6.1 HIV Therapeutics Market Concentration Rate

4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles

5.1 Boehringer Ingelheim International GmbH

5.1.1 Boehringer Ingelheim International GmbH Profile

5.1.2 Boehringer Ingelheim International GmbH Main Business

5.1.3 Boehringer Ingelheim International GmbH HIV Therapeutics Products, Services and Solutions

5.1.4 Boehringer Ingelheim International GmbH HIV Therapeutics Revenue (US$ Million) & (2018-2023)

5.1.5 Boehringer Ingelheim International GmbH Recent Developments

5.2 Merck & Co.

5.2.1 Merck & Co. Profile

5.2.2 Merck & Co. Main Business

5.2.3 Merck & Co. HIV Therapeutics Products, Services and Solutions

5.2.4 Merck & Co. HIV Therapeutics Revenue (US$ Million) & (2018-2023)

5.2.5 Merck & Co. Recent Developments

5.3 ViiV Healthcare

5.3.1 ViiV Healthcare Profile

5.3.2 ViiV Healthcare Main Business

5.3.3 ViiV Healthcare HIV Therapeutics Products, Services and Solutions

5.3.4 ViiV Healthcare HIV Therapeutics Revenue (US$ Million) & (2018-2023)

5.3.5 AbbVie Recent Developments

5.4 AbbVie

5.4.1 AbbVie Profile

5.4.2 AbbVie Main Business

5.4.3 AbbVie HIV Therapeutics Products, Services and Solutions

5.4.4 AbbVie HIV Therapeutics Revenue (US$ Million) & (2018-2023)

5.4.5 AbbVie Recent Developments

5.5 F. Hoffmann-La Roche Ltd.

5.5.1 F. Hoffmann-La Roche Ltd. Profile

5.5.2 F. Hoffmann-La Roche Ltd. Main Business

5.5.3 F. Hoffmann-La Roche Ltd. HIV Therapeutics Products, Services and Solutions

5.5.4 F. Hoffmann-La Roche Ltd. HIV Therapeutics Revenue (US$ Million) & (2018-2023)

5.5.5 F. Hoffmann-La Roche Ltd. Recent Developments

5.6 Teva Pharmaceutical Industries Ltd.

5.6.1 Teva Pharmaceutical Industries Ltd. Profile

5.6.2 Teva Pharmaceutical Industries Ltd. Main Business

5.6.3 Teva Pharmaceutical Industries Ltd. HIV Therapeutics Products, Services and Solutions

5.6.4 Teva Pharmaceutical Industries Ltd. HIV Therapeutics Revenue (US$ Million) & (2018-2023)

5.6.5 Teva Pharmaceutical Industries Ltd. Recent Developments

5.7 Bristol-Myers Squibb

5.7.1 Bristol-Myers Squibb Profile

5.7.2 Bristol-Myers Squibb Main Business

5.7.3 Bristol-Myers Squibb HIV Therapeutics Products, Services and Solutions

5.7.4 Bristol-Myers Squibb HIV Therapeutics Revenue (US$ Million) & (2018-2023)

5.7.5 Bristol-Myers Squibb Recent Developments

5.8 Gilead Sciences

5.8.1 Gilead Sciences Profile

5.8.2 Gilead Sciences Main Business

5.8.3 Gilead Sciences HIV Therapeutics Products, Services and Solutions

5.8.4 Gilead Sciences HIV Therapeutics Revenue (US$ Million) & (2018-2023)

5.8.5 Gilead Sciences Recent Developments

5.9 Johnson & Johnson

5.9.1 Johnson & Johnson Profile

5.9.2 Johnson & Johnson Main Business

5.9.3 Johnson & Johnson HIV Therapeutics Products, Services and Solutions

5.9.4 Johnson & Johnson HIV Therapeutics Revenue (US$ Million) & (2018-2023)

5.9.5 Johnson & Johnson Recent Developments

5.10 Cipla Limited

5.10.1 Cipla Limited Profile

5.10.2 Cipla Limited Main Business

5.10.3 Cipla Limited HIV Therapeutics Products, Services and Solutions

5.10.4 Cipla Limited HIV Therapeutics Revenue (US$ Million) & (2018-2023)

5.10.5 Cipla Limited Recent Developments

6 North America

6.1 North America HIV Therapeutics Market Size by Country (2018-2029)

6.2 U.S.

6.3 Canada

7 Europe

7.1 Europe HIV Therapeutics Market Size by Country (2018-2029)

7.2 Germany

7.3 France

7.4 U.K.

7.5 Italy

7.6 Russia

7.7 Nordic Countries

7.8 Rest of Europe

8 Asia-Pacific

8.1 Asia-Pacific HIV Therapeutics Market Size by Region (2018-2029)

8.2 China

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

8.6 India

8.7 Australia

8.8 Rest of Asia-Pacific

9 Latin America

9.1 Latin America HIV Therapeutics Market Size by Country (2018-2029)

9.2 Mexico

9.3 Brazil

9.4 Rest of Latin America

10 Middle East & Africa

10.1 Middle East & Africa HIV Therapeutics Market Size by Country (2018-2029)

10.2 Turkey

10.3 Saudi Arabia

10.4 UAE

10.5 Rest of Middle East & Africa

11 HIV Therapeutics Market Dynamics

11.1 HIV Therapeutics Industry Trends

11.2 HIV Therapeutics Market Drivers

11.3 HIV Therapeutics Market Challenges

11.4 HIV Therapeutics Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

FEATURED COMPANIES

Boehringer Ingelheim International GmbH

Merck

ViiV Healthcare

AbbVie

F Hoffmann La Roche Ltd

Teva Pharmaceutical Industries Ltd

List of Tables

Table 1. Global Market HIV Therapeutics Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029

Table 2. Global HIV Therapeutics Market Size by Region (2018-2023) & (US$ Million)

Table 3. Global HIV Therapeutics Market Size Share by Region (2018-2023)

Table 4. Global HIV Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 5. Global HIV Therapeutics Forecasted Market Size Share by Region (2024-2029)

Table 6. Global HIV Therapeutics Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029

Table 7. Global HIV Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 8. Global HIV Therapeutics Revenue Market Share by Type (2018-2023)

Table 9. Global HIV Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 10. Global HIV Therapeutics Revenue Market Share by Type (2024-2029)

Table 11. North America HIV Therapeutics Revenue by Type (2018-2023) & (US$ Million)

Table 12. North America HIV Therapeutics Revenue by Type (2024-2029) & (US$ Million)

Table 13. Europe HIV Therapeutics Revenue by Type (2018-2023) & (US$ Million)

Table 14. Europe HIV Therapeutics Revenue by Type (2024-2029) & (US$ Million)

Table 15. Asia-Pacific HIV Therapeutics Revenue by Type (2018-2023) & (US$ Million)

Table 16. Asia-Pacific HIV Therapeutics Revenue by Type (2024-2029) & (US$ Million)

Table 17. Latin America HIV Therapeutics Revenue by Type (2018-2023) & (US$ Million)

Table 18. Latin America HIV Therapeutics Revenue by Type (2024-2029) & (US$ Million)

Table 19. Middle East and Africa HIV Therapeutics Revenue by Type (2018-2023) & (US$ Million)

Table 20. Middle East and Africa HIV Therapeutics Revenue by Type (2024-2029) & (US$ Million)

Table 21. Global HIV Therapeutics Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029

Table 22. Global HIV Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 23. Global HIV Therapeutics Revenue Market Share by Application (2018-2023)

Table 24. Global HIV Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 25. Global HIV Therapeutics Revenue Market Share by Application (2024-2029)

Table 26. North America HIV Therapeutics Revenue by Application (2018-2023) & (US$ Million)

Table 27. North America HIV Therapeutics Revenue by Application (2024-2029) & (US$ Million)

Table 28. Europe HIV Therapeutics Revenue by Application (2018-2023) & (US$ Million)

Table 29. Europe HIV Therapeutics Revenue by Application (2024-2029) & (US$ Million)

Table 30. Asia-Pacific HIV Therapeutics Revenue by Application (2018-2023) & (US$ Million)

Table 31. Asia-Pacific HIV Therapeutics Revenue by Application (2024-2029) & (US$ Million)

Table 32. Latin America HIV Therapeutics Revenue by Application (2018-2023) & (US$ Million)

Table 33. Latin America HIV Therapeutics Revenue by Application (2024-2029) & (US$ Million)

Table 34. Middle East and Africa HIV Therapeutics Revenue by Application (2018-2023) & (US$ Million)

Table 35. Middle East and Africa HIV Therapeutics Revenue by Application (2024-2029) & (US$ Million)

Table 36. Global HIV Therapeutics Revenue (US$ Million) by Players (2018-2023)

Table 37. Global HIV Therapeutics Revenue Market Share by Players (2018-2023)

Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in HIV Therapeutics as of 2022)

Table 39. Date of Key Players Enter into HIV Therapeutics Market

Table 40. Global HIV Therapeutics Key Players Headquarters and Area Served

Table 41. HIV Therapeutics Product Solution and Service

Table 42. Global HIV Therapeutics Players Market Concentration Ratio (CR5 and HHI)

Table 43. Mergers & Acquisitions, Expansion Plans

Table 44. Boehringer Ingelheim International GmbH Basic Information List

Table 45. Boehringer Ingelheim International GmbH Description and Business Overview

Table 46. Boehringer Ingelheim International GmbH HIV Therapeutics Products, Services and Solutions

Table 47. Revenue (US$ Million) in HIV Therapeutics Business of Boehringer Ingelheim International GmbH (2018-2023)

Table 48. Boehringer Ingelheim International GmbH Recent Developments

Table 49. Merck & Co. Basic Information List

Table 50. Merck & Co. Description and Business Overview

Table 51. Merck & Co. HIV Therapeutics Products, Services and Solutions

Table 52. Revenue (US$ Million) in HIV Therapeutics Business of Merck & Co. (2018-2023)

Table 53. Merck & Co. Recent Developments

Table 54. ViiV Healthcare Basic Information List

Table 55. ViiV Healthcare Description and Business Overview

Table 56. ViiV Healthcare HIV Therapeutics Products, Services and Solutions

Table 57. Revenue (US$ Million) in HIV Therapeutics Business of ViiV Healthcare (2018-2023)

Table 58. ViiV Healthcare Recent Developments

Table 59. AbbVie Basic Information List

Table 60. AbbVie Description and Business Overview

Table 61. AbbVie HIV Therapeutics Products, Services and Solutions

Table 62. Revenue (US$ Million) in HIV Therapeutics Business of AbbVie (2018-2023)

Table 63. AbbVie Recent Developments

Table 64. F. Hoffmann-La Roche Ltd. Basic Information List

Table 65. F. Hoffmann-La Roche Ltd. Description and Business Overview

Table 66. F. Hoffmann-La Roche Ltd. HIV Therapeutics Products, Services and Solutions

Table 67. Revenue (US$ Million) in HIV Therapeutics Business of F. Hoffmann-La Roche Ltd. (2018-2023)

Table 68. F. Hoffmann-La Roche Ltd. Recent Developments

Table 69. Teva Pharmaceutical Industries Ltd. Basic Information List

Table 70. Teva Pharmaceutical Industries Ltd. Description and Business Overview

Table 71. Teva Pharmaceutical Industries Ltd. HIV Therapeutics Products, Services and Solutions

Table 72. Revenue (US$ Million) in HIV Therapeutics Business of Teva Pharmaceutical Industries Ltd. (2018-2023)

Table 73. Teva Pharmaceutical Industries Ltd. Recent Developments

Table 74. Bristol-Myers Squibb Basic Information List

Table 75. Bristol-Myers Squibb Description and Business Overview

Table 76. Bristol-Myers Squibb HIV Therapeutics Products, Services and Solutions

Table 77. Revenue (US$ Million) in HIV Therapeutics Business of Bristol-Myers Squibb (2018-2023)

Table 78. Bristol-Myers Squibb Recent Developments

Table 79. Gilead Sciences Basic Information List

Table 80. Gilead Sciences Description and Business Overview

Table 81. Gilead Sciences HIV Therapeutics Products, Services and Solutions

Table 82. Revenue (US$ Million) in HIV Therapeutics Business of Gilead Sciences (2018-2023)

Table 83. Gilead Sciences Recent Developments

Table 84. Johnson & Johnson Basic Information List

Table 85. Johnson & Johnson Description and Business Overview

Table 86. Johnson & Johnson HIV Therapeutics Products, Services and Solutions

Table 87. Revenue (US$ Million) in HIV Therapeutics Business of Johnson & Johnson (2018-2023)

Table 88. Johnson & Johnson Recent Developments

Table 89. Cipla Limited Basic Information List

Table 90. Cipla Limited Description and Business Overview

Table 91. Cipla Limited HIV Therapeutics Products, Services and Solutions

Table 92. Revenue (US$ Million) in HIV Therapeutics Business of Cipla Limited (2018-2023)

Table 93. Cipla Limited Recent Developments

Table 94. North America HIV Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 95. North America HIV Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 96. Europe HIV Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 97. Europe HIV Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 98. Asia-Pacific HIV Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 99. Asia-Pacific HIV Therapeutics Market Size by Region (2018-2023) & (US$ Million)

Table 100. Asia-Pacific HIV Therapeutics Market Size by Region (2024-2029) & (US$ Million)

Table 101. Asia-Pacific HIV Therapeutics Market Share by Region (2018-2023)

Table 102. Asia-Pacific HIV Therapeutics Market Share by Region (2024-2029)

Table 103. Latin America HIV Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 104. Latin America HIV Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 105. Latin America HIV Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 106. Middle East & Africa HIV Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 107. Middle East & Africa HIV Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 108. Middle East & Africa HIV Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 109. HIV Therapeutics Market Trends

Table 110. HIV Therapeutics Market Drivers

Table 111. HIV Therapeutics Market Challenges

Table 112. HIV Therapeutics Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

List of Figures

Figure 1. Global HIV Therapeutics Market Size Year-over-Year 2018-2029 & (US$ Million)

Figure 2. Global HIV Therapeutics Market Size (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global HIV Therapeutics Market Share by Regions: 2022 VS 2029

Figure 4. Global HIV Therapeutics Forecasted Market Size Share by Region (2024-2029)

Figure 5. North America HIV Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 6. Europe HIV Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 7. Asia-Pacific HIV Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 8. Latin America HIV Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 9. Middle East & Africa HIV Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 10. Product Picture of Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)

Figure 11. Global Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 12. Product Picture of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

Figure 13. Global Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 14. Product Picture of Entry and Fusion Inhibitors

Figure 15. Global Entry and Fusion Inhibitors Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 16. Product Picture of Protease Inhibitors (PIs)

Figure 17. Global Protease Inhibitors (PIs) Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 18. Product Picture of Integrase Inhibitors

Figure 19. Global Integrase Inhibitors Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 20. Product Picture of Coreceptor Antagonists

Figure 21. Global Coreceptor Antagonists Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 22. Global HIV Therapeutics Market Size Share by Type: 2022 & 2029

Figure 23. North America HIV Therapeutics Revenue Market Share by Type (2018-2029)

Figure 24. Europe HIV Therapeutics Revenue Market Share by Type (2018-2029)

Figure 25. Asia-Pacific HIV Therapeutics Revenue Market Share by Type (2018-2029)

Figure 26. Latin America HIV Therapeutics Revenue Market Share by Type (2018-2029)

Figure 27. Middle East and Africa HIV Therapeutics Revenue Market Share by Type (2018-2029)

Figure 28. Hospitals Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 29. Clinics Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 30. Labs Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 31. Global HIV Therapeutics Market Size Share by Application: 2022 & 2029

Figure 32. North America HIV Therapeutics Revenue Market Share by Application (2018-2029)

Figure 33. Europe HIV Therapeutics Revenue Market Share by Application (2018-2029)

Figure 34. Asia-Pacific HIV Therapeutics Revenue Market Share by Application (2018-2029)

Figure 35. Latin America HIV Therapeutics Revenue Market Share by Application (2018-2029)

Figure 36. Middle East and Africa HIV Therapeutics Revenue Market Share by Application (2018-2029)

Figure 37. HIV Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

Figure 38. Global Top 5 and Top 10 Players HIV Therapeutics Market Share in 2022

Figure 39. North America HIV Therapeutics Market Share by Country (2018-2029)

Figure 40. U.S. HIV Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 41. Canada HIV Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 42. Germany HIV Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 43. France HIV Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 44. U.K. HIV Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 45. Italy HIV Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 46. Russia HIV Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 47. Nordic Countries HIV Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 48. Asia-Pacific HIV Therapeutics Market Share by Region (2018-2029)

Figure 49. China HIV Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 50. Japan HIV Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 51. South Korea HIV Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 52. Southeast Asia HIV Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 53. India HIV Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 54. Australia HIV Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 55. Latin America HIV Therapeutics Market Share by Country (2018-2029)

Figure 56. Mexico HIV Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 57. Brazil HIV Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 58. Middle East & Africa HIV Therapeutics Market Share by Country (2018-2029)

Figure 59. Turkey HIV Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 60. Saudi Arabia HIV Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 61. UAE HIV Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 62. Bottom-up and Top-down Approaches for This Report

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions